GlassScriptPhysician profile
Taylor A Shepard
NPI 1689332496
$2,341.15
in general payments reported to CMS, 2019-2025
17 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.75 · 2022: $1,541 · 2023: $137 · 2024: $377 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $925.57 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $210.18 | 2023-2025 | Euflexxa |
| Endo Pharmaceuticals INC. | $171.86 | 2024 | Xiaflex |
| Amgen INC. | $150.98 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $141.38 | 2022 | |
| Bioventus LLC | $132.64 | 2023-2025 | Durolane, Durolane |
| Glaxosmithkline, LLC. | $123.90 | 2022-2025 | Nucala |
| Aurinia Pharma U.S., INC. | $97.45 | 2022 | |
| Lilly USA, LLC | $90.99 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $80.89 | 2022 | |
| Ucb, INC. | $68.74 | 2022 | |
| Depuy Synthes Sales INC. | $50.24 | 2024-2025 | Orthovisc, Monovisc |
| Pacira Pharmaceuticals Incorporated | $20.34 | 2025 | Iovera |
| Smith+Nephew, INC. | $19.71 | 2025 | Pico 14 |
| Pfizer INC. | $19.19 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $19.13 | 2023 | Multitom Rax |
| Averitas Pharma INC. | $17.96 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Shepard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.